At a glance
The MoneyTree™ Report, a collaboration between PricewaterhouseCoopers and the National Venture Capital Association based upon data from Thomson Reuters, is a quarterly study of venture capital investment activity in the United States.
For the most recent quarter's results including VC and company lists, as well as aggregate trend data dating back to 1995, visit our interactive MoneyTree™ Report site: pwcmoneytree.com
At a glance
The Shaking the MoneyTree™ Q2 2016 Update provides readers with the results and trends of investments by the professional venture capital community into emerging companies, going back as far as 1995.
Additional details can be found on the MoneyTree™ site: pwcmoneytree.com
PwC's Life Sciences MoneyTree Report breaks down investments in life sciences by quarter, stages, and regional funding trends. The data is also broken down into subsegments, including biotech and medical device, to compare funding and investment trends by quarter.
With technology and innovation coming of age in many emerging countries, these fast-growing markets are important destinations for private equity. Together with our US MoneyTree™ Report, these reports will help you compare trends in various parts of the world and provide a truly global view of VC/PE investments. The global MoneyTree reports serve as a reliable source of current and recent trends in PE/VC funding for: Israel, India, Russia and China.